GIE Medical, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

GIE Medical, Inc. - overview

Established

2018

Location

Brooklyn Park, MN, US

Primary Industry

Medical Devices & Equipment

About

Based in Minnesota, US, and founded by Lixiao Wang (CEO) in 2018, GIE Medical, Inc. , a spun out of Urotronic, Inc. operates as a clinical-stage medical equipment manufacturing company. In September 2023, the firm was acquired by Laborie Medical Technologies Corp.


, a portfolio of Patricia Industries, for USD 5 million. The company develops technologies in the field of gastroenterology to overcome the challenges faced by patients suffering from benign strictures of the esophagus and bowel, specifically the small intestine, colon, and rectum. GIE Medical has launched two large, multicenter randomized controlled clinical trials in the US, and the solution offered by the firm is ProTractX3™ 3-Stage TTS DCB (Drug-Coated Balloon), an investigational device in the US. ProTractX3™ 3-Stage TTS DCB has the potential to provide sustained patency, reducing the need for frequent treatments and enhancing patients' overall well-being.


Current Investors

Laborie Medical Technologies Corp.

Primary Industry

Medical Devices & Equipment

Sub Industries

Surgical Devices

Website

www.giemedical.com

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

GIE Medical, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedGIE Medical, Inc.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.